These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo. Horwitz JA; Bar-On Y; Lu CL; Fera D; Lockhart AAK; Lorenzi JCC; Nogueira L; Golijanin J; Scheid JF; Seaman MS; Gazumyan A; Zolla-Pazner S; Nussenzweig MC Cell; 2017 Aug; 170(4):637-648.e10. PubMed ID: 28757252 [TBL] [Abstract][Full Text] [Related]
9. Antibody inhibition of influenza A virus assembly and release. He Y; Guo Z; Subiaur S; Benegal A; Vahey MD J Virol; 2024 Feb; 98(2):e0139823. PubMed ID: 38179944 [TBL] [Abstract][Full Text] [Related]
10. Broadly neutralizing antibodies to combat influenza virus infection. Sun X; Ma H; Wang X; Bao Z; Tang S; Yi C; Sun B Antiviral Res; 2024 Jan; 221():105785. PubMed ID: 38145757 [TBL] [Abstract][Full Text] [Related]
11. Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses. Rijnink WF; Stadlbauer D; Puente-Massaguer E; Okba NMA; Kirkpatrick Roubidoux E; Strohmeier S; Mudd PA; Schmitz A; Ellebedy A; McMahon M; Krammer F J Virol; 2023 Nov; 97(11):e0164622. PubMed ID: 37916834 [TBL] [Abstract][Full Text] [Related]
12. Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers. Biswas S; Mandal G; Anadon CM; Chaurio RA; Lopez-Bailon LU; Nagy MZ; Mine JA; Hänggi K; Sprenger KB; Innamarato P; Harro CM; Powers JJ; Johnson J; Fang B; Eysha M; Nan X; Li R; Perez BA; Curiel TJ; Yu X; Rodriguez PC; Conejo-Garcia JR Immunity; 2023 Nov; 56(11):2570-2583.e6. PubMed ID: 37909039 [TBL] [Abstract][Full Text] [Related]